-
60mg • 5mL Vial
ARA-290, also known as cibinetide, is a synthetic peptide studied for its interaction with the innate repair receptor (IRR), a receptor complex involved in tissue protection and repair signaling. Research has examined its potential effects on inflammation, nerve function, tissue recovery, and neuropathic discomfort.
Unlike full erythropoietin (EPO), ARA-290 has been designed to activate tissue-protective pathways without stimulating red blood cell production, making it a compound of interest in neuroprotection, regenerative signaling, and inflammatory research.
-
30mg • 5mL Vial
BPC-157 is a synthetic peptide explored for its role in cellular modeling and signaling pathways within controlled research environments. Minimal structure. Precise investigative utility.
-
30mg, 60mg • 5mL Vial
The BPC-157 + TB-500 Blend brings together two peptides frequently examined for their roles in cellular organization and structural pathway modeling. Focused sequences. Clear investigational value for controlled research environments.
-
30mg • 5mL Vial
TB-500 is a fragment of Thymosin Beta-4 studied for its role in actin-related pathways and cellular modeling within controlled research environments. Focused structure. Clear investigative potential.
-
1mg • 60 Capsules, 90 Capsules
BPC-157 (Body Protection Compound-157) is a naturally derived research peptide that has been studied for its potential role in supporting cellular repair and maintaining a healthy gastrointestinal environment. Early research suggests it may help promote tissue recovery and reduce localized inflammation through modulation of growth and repair pathways. Oral formulations are being explored for stability and systemic effects related to gut integrity and overall wellness.
